Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9NYR8
UPID:
RDH8_HUMAN
Alternative names:
Photoreceptor outer segment all-trans retinol dehydrogenase; Short chain dehydrogenase/reductase family 28C member 2
Alternative UPACC:
Q9NYR8; Q9H838
Background:
Retinol dehydrogenase 8 (RDH8), also known as Photoreceptor outer segment all-trans retinol dehydrogenase and Short chain dehydrogenase/reductase family 28C member 2, plays a pivotal role in the visual cycle. It specifically catalyzes the conversion of all-trans-retinal to all-trans-retinol, a critical reaction in the regeneration of visual pigment under high light intensity conditions.
Therapeutic significance:
Understanding the role of Retinol dehydrogenase 8 could open doors to potential therapeutic strategies.